Functional cardiac Na+ channels are expressed in human melanoma cells

Membrane Transporters and Channels in Melanoma

Recent research has revealed that ion channels and transporters can be important players in tumor development, progression, and therapy resistance in melanoma. For example, members of the ABC family were shown to support cancer stemness-like features in melanoma cells, while several members of the TRP channel family were reported to act as tumor suppressors.Also, many transporter proteins support tumor cell viability and thus suppress apoptosis induction by anticancer therapy. Due to the high number of ion channels and transporters and the resulting high complexity of the field, progress in understanding is often focused on single molecules and is in total rather slow. In this review, we aim at giving an overview about a broad subset of ion transporters, also illustrating some aspects of the field, which have not been addressed in detail in melanoma. In context with the other chapters in this special issue on "Transportome Malfunctions in the Cancer Spectrum," a comparison between melanoma and these tumors will be possible.

[Effect of calmodulin and its mutants on binding to NaV1.2 IQ]

OBJECTIVE

To investigate the effect of calmodulin (CaM) and its mutants on binding to voltage-gated Na channel isoleucine-glutamine domain (Na_V1.2 IQ).

METHODS

The cDNA of Na_V1.2 IQ was constructed by PCR technique, CaM mutants CaM₁₂, CaM₃₄ and CaM₁₂₃₄ were constructed with Quickchange^TM site-directed mutagenesis kit (QIAGEN). The binding of Na_V1.2 IQ to CaM and CaM mutants under calcium and calcium free conditions were detected by pull-down assay.

RESULTS

Na_V1.2 IQ and CaM were bound to each other at different calcium concentrations, while GST alone did not bind to CaM. The binding affinity of CaM and Na_V1.2 IQ at [Ca²⁺]-free was greater than that at 100 nmol/L [Ca²⁺] (P < 0.05). In the absence of calcium, the binding amount of CaM wild-type to Na_V1.2 IQ was greater than that of its mutant, and the binding affinity of CaM₁₂₃₄ to Na_V1.2 IQ was the weakest among the three mutants (P < 0.05).

CONCLUSIONS

The binding ability of CaM and CaM mutants to Na_V1.2 IQ is Ca²⁺-dependent. This study has revealed a new mechanism of Na_V1.2 regulated by CaM, which would be useful for the study of ion channel related diseases.

In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis

A wide body of evidence suggests that voltage-gated sodium channels (VGSCs) are expressed de novo in several human carcinomas where channel activity promotes a variety of cellular behaviours integral to the metastatic cascade. These include directional motility (including galvanotaxis), pH balance, extracellular proteolysis, and invasion. Contrary to the substantial in vitro data, however, evidence for VGSC involvement in the cancer process in vivo is limited. Here, we critically assess, for the first time, the available in vivo evidence, hierarchically from mRNA level to emerging clinical aspects, including protein-level studies, electrolyte content, animal tests, and clinical imaging. The evidence strongly suggests that different VGSC subtypes (mainly Nav1.5 and Nav1.7) are expressed de novo in human carcinoma tissues and generally parallel the situation in vitro. Consistent with this, tissue electrolyte (sodium) levels, quantified by clinical imaging, are significantly higher in cancer vs. matched non-cancer tissues. These are early events in the acquisition of metastatic potential by the cancer cells. Taken together, the multi-faceted evidence suggests that the VGSC expression has clinical (diagnostic and therapeutic) potential as a prognostic marker, as well as an anti-metastatic target. The distinct advantages offered by the VGSC include especially (1) its embryonic nature, demonstrated most clearly for the predominant neonatal Nav1.5 expression in breast and colon cancer, and (2) the specifically druggable persistent current that VGSCs develop under hypoxic conditions, as in growing tumours, which promotes invasiveness and metastasis.